Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Muehlematter UJ"" wg kryterium: Autor


Tytuł :
PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
Autorzy :
Husmann L; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland. Electronic address: .
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland.
Grimm F; Institute of Parasitology, University of Zurich, Switzerland.
Ledergerber B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland.
Kudura K; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland.
Gruenig H; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland.
Muellhaupt B; Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Switzerland.
Hasse B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
Huellner MW; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland.
Pokaż więcej
Źródło :
Parasitology international [Parasitol Int] 2021 Aug; Vol. 83, pp. 102356. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Value of bowel preparation techniques for prostate MRI: a preliminary study.
Autorzy :
Schmidt C; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Hötker AM; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.; Department of Nuclear Medicine, Cantonal Hospital Baden, Im Ergel 1, 5404, Baden, Switzerland.
Donati OF; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Barth BK; University of Zurich (UZH), Raemistrasse 71, 8006, Zurich, Switzerland. .
Pokaż więcej
Źródło :
Abdominal radiology (New York) [Abdom Radiol (NY)] 2021 Aug; Vol. 46 (8), pp. 4002-4013. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
[ F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.
Autorzy :
Skawran S; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Gennari AG; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Dittli M; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Treyer V; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Maurer A; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland.
Mader C; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Messerli O; University of Zurich, Zurich, Switzerland.; Department of Dermatology, University Hospital Zurich, Zürich, Switzerland.
Grünig H; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Gebhard C; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Huellner MW; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Curioni-Fontecedro A; University of Zurich, Zurich, Switzerland.; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
Berger C; University of Zurich, Zurich, Switzerland.; Division of Infectious Diseases and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland. .; University of Zurich, Zurich, Switzerland. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Jun 22. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors.
Autorzy :
Schneider MA; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Linecker M; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Fritsch R; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Oncology, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Muehlematter UJ; Institute of Interventional and Diagnostic Radiology, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Stocker D; Institute of Interventional and Diagnostic Radiology, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Pestalozzi B; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Oncology, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Samaras P; Oncology Center, Hirslanden Hospital Zurich, Witellikerstrasse 40, Zurich, Switzerland.
Jetter A; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Kron P; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Petrowsky H; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Nicolau C; Friedman School of Nutrition Science and Policy, Tufts University, 150 Harrison Ave, Boston, MA, USA.
Lehn JM; Institut de Science et d'Ingénierie Supramoléculaires (ISIS), Université de Strasbourg, 8 allée Gaspard Monge, Strasbourg, France.
Humar B; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Graf R; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Clavien PA; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland. .; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland. .
Limani P; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland. .; Department of Surgery & Transplantation, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jun 21; Vol. 12 (1), pp. 3807. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Digestive System Neoplasms/*drug therapy
Hypoxia/*drug therapy
Inositol Phosphates/*therapeutic use
Administration, Intravenous ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/blood ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/pathology ; Digestive System Neoplasms/pathology ; Female ; Humans ; Inositol Phosphates/pharmacokinetics ; Liver Neoplasms/drug therapy ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Progression-Free Survival
Czasopismo naukowe
Tytuł :
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.
Autorzy :
Kudura K; Department of Nuclear Medicine, University Hospital Zurich, 8006 Zurich, Switzerland.; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.
Dimitriou F; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.; Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Mihic-Probst D; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.; Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, 8006 Zurich, Switzerland.; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.
Kutzker T; Faculty of Applied Statistics, Humboldt University Berlin, 10117 Berlin, Germany.
Basler L; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.; Center for Proton Therapy, Paul Scherrer Institute, 5232 Villigen, Switzerland.
Förster R; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.; Institute of Radiation Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.
Dummer R; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.; Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Mangana J; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.; Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Husmann L; Department of Nuclear Medicine, University Hospital Zurich, 8006 Zurich, Switzerland.; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, 8006 Zurich, Switzerland.; Faculty of Medicine, University of Zurich, 8091 Zurich, Switzerland.
Kreissl MC; Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.
Pokaż więcej
Źródło :
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 May 15; Vol. 11 (5). Date of Electronic Publication: 2021 May 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
Autorzy :
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.
Daniore P; Institute of Law, University of Zurich, Switzerland.
Vokinger KN; Institute of Law, University of Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Digital health [Lancet Digit Health] 2021 Mar; Vol. 3 (3), pp. e195-e203. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Comparative Study; Journal Article; Review
MeSH Terms :
Artificial Intelligence*
Biomedical Technology*
Equipment and Supplies*
Government Regulation*
Machine Learning*
Databases, Factual ; Device Approval ; Europe ; Humans ; Radiology ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET.
Autorzy :
Messerli M; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; Maastricht UMC+, Heart and Vascular Center, Maastricht, the Netherlands.; University of Zurich (UZH), Zurich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; University of Zurich (UZH), Zurich, Switzerland.; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Fassbind S; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; University of Zurich (UZH), Zurich, Switzerland.
Franzen D; University of Zurich (UZH), Zurich, Switzerland.; Department of Pulmonary Medicine, University Hospital Zurich, Zurich, Switzerland.
Ferraro DA; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Huellner MW; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; University of Zurich (UZH), Zurich, Switzerland.
Treyer V; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; University of Zurich (UZH), Zurich, Switzerland.
Curioni-Fontecedro A; University of Zurich (UZH), Zurich, Switzerland.; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.; University of Zurich (UZH), Zurich, Switzerland.; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 Mar 01; Vol. 94 (1119), pp. 20200244. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Radiopharmaceuticals*
Lung Neoplasms/*diagnostic imaging
Lung Neoplasms/*metabolism
Positron-Emission Tomography/*methods
Aged ; Cohort Studies ; Female ; Humans ; Lung/diagnostic imaging ; Lung/metabolism ; Male ; Pilot Projects ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Manual prostate cancer segmentation in MRI: interreader agreement and volumetric correlation with transperineal template core needle biopsy.
Autorzy :
Liechti MR; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland.
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland.
Schneider AF; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland.
Eberli D; Department of Urology, University Hospital of Zurich, Zurich, Switzerland.
Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
Hötker AM; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland.
Donati OF; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland.
Becker AS; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich, Zurich, Switzerland. .; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2020 Sep; Vol. 30 (9), pp. 4806-4815. Date of Electronic Publication: 2020 Apr 19.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Grading*
Biopsy, Large-Core Needle/*methods
Magnetic Resonance Imaging/*methods
Prostatic Neoplasms/*diagnosis
Aged ; Biopsy ; Humans ; Male ; Middle Aged ; Perineum ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions.
Autorzy :
Svirydenka H; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; Department of Nuclear Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Nagel HW; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; Department of Radiology and Nuclear Medicine, Kantonsspital Winterthur, Brauerstrasse 15, 8401, Winterthur, Switzerland.
Delso G; GE Healthcare, 3000 N Grandview Blvd, Waukesha, WI, 53188, USA.
Ferraro DA; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Kudura K; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; Department of Nuclear Medicine, Kantonsspital Baden, Im Ergel 1, 5404, Baden, Switzerland.
Ter Voert EEGW; Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. .; University of Zurich, Rämistrasse 71, 8006, Zurich, Switzerland. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2020 Jun; Vol. 30 (6), pp. 3188-3197. Date of Electronic Publication: 2020 Feb 14.
Typ publikacji :
Journal Article
MeSH Terms :
Gallium Radioisotopes/*administration & dosage
Membrane Glycoproteins/*administration & dosage
Organometallic Compounds/*administration & dosage
Pelvis/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Prostate/*diagnostic imaging
Aged ; Algorithms ; Antigens, Surface ; Glutamate Carboxypeptidase II ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/diagnostic imaging ; Radiation Dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with Ga-PSMA-11-PET.
Autorzy :
Ferraro DA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Zurich, Switzerland.
Rüschoff JH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Zurich, Switzerland.; Department of Interventional and Diagnostic Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Kranzbühler B; Department of Urology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
Müller J; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Zurich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Zurich, Switzerland.
Husmann L; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Zurich, Switzerland.
Hermanns T; Department of Urology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
Eberli D; Department of Urology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.
Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Zurich, Switzerland.; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland.
Pokaż więcej
Źródło :
Theranostics [Theranostics] 2020 May 15; Vol. 10 (14), pp. 6082-6094. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Surface/*metabolism
Biomarkers, Tumor/*metabolism
Edetic Acid/*analogs & derivatives
Glutamate Carboxypeptidase II/*metabolism
Neoplasm Recurrence, Local/*pathology
Oligopeptides/*metabolism
Positron Emission Tomography Computed Tomography/*methods
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*pathology
Aged ; Androgen Antagonists/therapeutic use ; Edetic Acid/metabolism ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/metabolism ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/metabolism ; Radiopharmaceuticals/metabolism ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Accessibility of cancer drugs in Switzerland: Time from approval to pricing decision between 2009 and 2018.
Autorzy :
Vokinger KN; Institute of Law, and Lab for Technology, Markets and Regulation, University of Zurich, Zurich, Switzerland; Institute for Primary Care, University Hospital of Zurich and University of Zurich, Zurich, Switzerland. Electronic address: .
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital of Zurich / University of Zurich, Department of Nuclear Medicine, University Hospital of Zurich/University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
Health policy (Amsterdam, Netherlands) [Health Policy] 2020 Mar; Vol. 124 (3), pp. 261-267. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Drug Costs*
Neoplasms*/drug therapy
Costs and Cost Analysis ; Drug Approval ; Humans ; Switzerland
Czasopismo naukowe
Tytuł :
Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer.
Autorzy :
Ferraro DA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Garcia Schüler HI; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.; Department of Interventional and Diagnostic Radiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Eberli D; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Müller J; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Müller A; Department of Urology, Spital Limmattal, Schlieren, Switzerland.
Gablinger R; Uroviva, Zürich, Switzerland.
Kranzbühler H; Department of Radiation Oncology, Stadtspital Triemli, Zürich, Switzerland.
Omlin A; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, University of Bern, Bern, Switzerland.
Kaufmann PA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Hermanns T; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland. .; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Mar; Vol. 47 (3), pp. 652-664. Date of Electronic Publication: 2019 Dec 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/therapy
Clinical Decision-Making ; Edetic Acid/analogs & derivatives ; Humans ; Male ; Neoplasm Staging ; Oligopeptides ; Positron-Emission Tomography ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer.
Autorzy :
Ferraro DA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zürich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zürich, Switzerland.; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Garcia Schüler HI; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Huellner M; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zürich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zürich, Switzerland.
Rüschoff JH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Ter Voert EEGW; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zürich, Switzerland.
Hermanns T; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zürich, Switzerland. .; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Jan; Vol. 47 (1), pp. 147-159. Date of Electronic Publication: 2019 Sep 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymph Node Excision*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Edetic Acid/analogs & derivatives ; Humans ; Lymph Nodes/pathology ; Male ; Neoplasm Staging ; Oligopeptides ; Patient Selection ; Prostatectomy
Czasopismo naukowe
Tytuł :
Variability of manual segmentation of the prostate in axial T2-weighted MRI: A multi-reader study.
Autorzy :
Becker AS; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, USA. Electronic address: .
Chaitanya K; Computer Vision Laboratory, Department of Information Technology and Electrical Engineering, ETH Zurich, Switzerland.
Schawkat K; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Hötker AM; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Konukoglu E; Computer Vision Laboratory, Department of Information Technology and Electrical Engineering, ETH Zurich, Switzerland.
Donati OF; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2019 Dec; Vol. 121, pp. 108716. Date of Electronic Publication: 2019 Oct 25.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Image Interpretation, Computer-Assisted/*methods
Magnetic Resonance Imaging/*methods
Prostate/*diagnostic imaging
Prostatic Neoplasms/*diagnostic imaging
Humans ; Male ; Middle Aged ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Diagnostic Accuracy of Multiparametric MRI versus Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer.
Autorzy :
Muehlematter UJ; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Burger IA; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Becker AS; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Schawkat K; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Hötker AM; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Reiner CS; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Müller J; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Rupp NJ; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Rüschoff JH; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Eberli D; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Donati OF; From the Institute of Diagnostic and Interventional Radiology (U.J.M., A.S.B., K.S., A.M.H., C.S.R., O.F.D.), Department of Nuclear Medicine (U.J.M., I.A.B., J.M.), Department of Pathology and Molecular Pathology (N.J.R., J.H.R.), and Department of Urology (D.E.), University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland; and Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland (I.A.B.).
Pokaż więcej
Źródło :
Radiology [Radiology] 2019 Nov; Vol. 293 (2), pp. 350-358. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Multimodal Imaging*
Neoplasm Invasiveness/*diagnostic imaging
Prostatic Neoplasms/*diagnostic imaging
Seminal Vesicles/*diagnostic imaging
Aged ; Edetic Acid/analogs & derivatives ; Humans ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Oligopeptides ; Positron-Emission Tomography ; Prostatectomy ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Radiopharmaceuticals ; Seminal Vesicles/pathology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for Ga-PSMA-11 in Salivary Glands.
Autorzy :
Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Switzerland.
Umbricht CA; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland.
Pizzuto DA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland.
Lenggenhager D; Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Switzerland.
Töpfer A; Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Switzerland.
Müller J; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland.
Ferraro DA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland.
Morand GB; Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital Zürich, University of Zürich, Switzerland.
Huber GF; Department of Otorhinolaryngology - Head and Neck Surgery, Kantonsspital St. Gallen, Switzerland; and.
Eberli D; Department of Urology, University Hospital Zürich, University of Zürich, Switzerland.
Schibli R; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland.
Müller C; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland .
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Sep; Vol. 60 (9), pp. 1270-1276. Date of Electronic Publication: 2019 Feb 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Surface/*metabolism
Dipeptides/*chemistry
Glutamate Carboxypeptidase II/*metabolism
Heterocyclic Compounds, 1-Ring/*chemistry
Membrane Glycoproteins/*chemistry
Organometallic Compounds/*chemistry
Salivary Glands/*diagnostic imaging
Submandibular Gland/*diagnostic imaging
Aged ; Animals ; Autoradiography ; Cell Line, Tumor ; Humans ; Image Processing, Computer-Assisted ; Immunohistochemistry ; Magnetic Resonance Imaging ; Mice ; Middle Aged ; Neoplasm Transplantation ; Pancreas/diagnostic imaging ; Positron-Emission Tomography ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU.
Autorzy :
Burger IA; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland .
Müller J; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.
Donati OF; Institute of Diagnostic and Interventional Radiology, University Hospital Zürich, Zürich, Switzerland.
Ferraro DA; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.
Messerli M; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.
Kranzbühler B; Department of Urology, University Hospital Zürich, Zürich, Switzerland.
Ter Voert EEGW; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.; University of Zurich, Zürich, Switzerland; and.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.
Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland.
Mortezavi A; Department of Urology, University Hospital Zürich, Zürich, Switzerland.
Eberli D; Department of Urology, University Hospital Zürich, Zürich, Switzerland.
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Aug; Vol. 60 (8), pp. 1118-1123. Date of Electronic Publication: 2019 Jan 25.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
High-Intensity Focused Ultrasound Ablation*
Multiparametric Magnetic Resonance Imaging*
Positron-Emission Tomography*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*therapy
Aged ; Biopsy ; False Negative Reactions ; Humans ; Male ; Membrane Glycoproteins ; Middle Aged ; Neoplasm Recurrence, Local ; Observer Variation ; Organometallic Compounds ; Prospective Studies ; Radiopharmaceuticals ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Vertebral body insufficiency fractures: detection of vertebrae at risk on standard CT images using texture analysis and machine learning.
Autorzy :
Muehlematter UJ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland. urs.muehlematter@usz.ch.
Mannil M; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Becker AS; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Vokinger KN; University Hospital of Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.
Finkenstaedt T; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Osterhoff G; Department of Trauma, University Hospital Zurich, Zurich, Switzerland.
Fischer MA; Department of Radiology, University Hospital Balgrist, University of Zurich, Zurich, Switzerland.
Guggenberger R; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland.
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2019 May; Vol. 29 (5), pp. 2207-2217. Date of Electronic Publication: 2018 Dec 05.
Typ publikacji :
Journal Article
MeSH Terms :
Machine Learning*
Fractures, Stress/*diagnosis
Lumbar Vertebrae/*injuries
Spinal Fractures/*diagnosis
Thoracic Vertebrae/*injuries
Tomography, X-Ray Computed/*methods
Aged ; Aged, 80 and over ; Bone Density ; Case-Control Studies ; Female ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Male ; Middle Aged ; ROC Curve ; Retrospective Studies ; Thoracic Vertebrae/diagnostic imaging
Czasopismo naukowe
Tytuł :
Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.
Autorzy :
Müller J; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Ferraro DA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Muehlematter UJ; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.; Department of Interventional and Diagnostic Radiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Garcia Schüler HI; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Kedzia S; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Eberli D; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Kroeze SGC; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Sulser T; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Schmid DM; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Omlin A; Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Müller A; Department of Urology, Spital Limmattal, Schlieren, Switzerland.
Zilli T; Department of Radiation Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
John H; Department of Urology, Kantonsspital Winterthur, Winterthur, Switzerland.
Kranzbuehler H; Department of Radiation Oncology, Stadtspital Triemli, Zürich, Switzerland.
Kaufmann PA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
von Schulthess GK; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Burger IA; Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Rämistrasse 100, 8091, Zürich, Switzerland. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Apr; Vol. 46 (4), pp. 889-900. Date of Electronic Publication: 2018 Nov 28.
Typ publikacji :
Journal Article
MeSH Terms :
Oligopeptides*
Positron-Emission Tomography*
Edetic Acid/*analogs & derivatives
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*diagnostic imaging
Aged ; Aged, 80 and over ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged ; Neoplasm Metastasis ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Recurrence ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
Autorzy :
Messerli M; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Kotasidis F; 2 GE Healthcare , Waukesha, WI , USA.
Burger IA; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Ferraro DA; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Muehlematter UJ; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.; 3 Institute of Diagnostic and Interventional Radiology, University Hospital Zurich / University of Zurich , Switzerland.
Weyermann C; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Kenkel D; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.; 3 Institute of Diagnostic and Interventional Radiology, University Hospital Zurich / University of Zurich , Switzerland.
von Schulthess GK; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Kaufmann PA; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Huellner MW; 1 Department of Nuclear Medicine, University Hospital Zurich / University of Zurich , Switzerland.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2019 Apr; Vol. 92 (1096), pp. 20180792. Date of Electronic Publication: 2019 Feb 26.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Adenocarcinoma/*diagnostic imaging
Carcinoma, Non-Small-Cell Lung/*diagnostic imaging
Carcinoma, Squamous Cell/*diagnostic imaging
Image Processing, Computer-Assisted/*methods
Lung Neoplasms/*diagnostic imaging
Positron-Emission Tomography/*methods
Aged ; Aged, 80 and over ; Female ; Humans ; Lung/diagnostic imaging ; Male ; Middle Aged ; Reproducibility of Results
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies